Trial Profile
INTRACORONARY ADMINISTRATION OF TENECTEPLASE VERSUS ABCIXIMAB AS ADJUNCTIVE TREATMENT DURING PRIMARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION OF ANTERIOR LOCATION ADMINISTRACION. [INTRACORONARIA DE TENECTEPLASA FRENTE A ABCIXIMAB COMO TRATAMIENTO ADJUNTO DURANTE ANGIOPLASTIA PRIMARIA EN INFARTO AGUDO DE MIOCARDIO DE LOCALIZACION ANTERIOR.]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2013
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary) ; Abciximab
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- 26 Apr 2012 New trial record